Grand Pharmaceutical Group Limited's total assets for Q4 2024 were HK$24.99B, an increase of 0.36% from the previous quarter. HK:0512 total liabilities were HK$8.47B for the fiscal quarter, a -5.98% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.